Manulife (Manufacturers Life Insurance)
ATRA icon

Manulife (Manufacturers Life Insurance)’s Atara Biotherapeutics ATRA Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-12,487
Closed -$217K – 2970
2024
Q1 		$217K Buy
12,487
+11,480
+1,140% +$204K ﹤0.01% 2561
2023
Q4 		$12.9K Sell
1,007
-716
-42% -$16.7K ﹤0.01% 2950
2023
Q3 		$63.8K Hold
1,723
– – ﹤0.01% 2914
2023
Q2 		$69.4K Buy
1,723
+243
+16% +$13.7K ﹤0.01% 2938
2023
Q1 		$107K Hold
1,480
– – ﹤0.01% 2729
2022
Q4 		$121K Sell
1,480
-8
-0.5% -$834 ﹤0.01% 2750
2022
Q3 		$141K Buy
1,488
+1
+0.1% +$112 ﹤0.01% 2715
2022
Q2 		$290K Buy
1,487
+72
+5% +$11.8K ﹤0.01% 2421
2022
Q1 		$329K Sell
1,415
-337
-19% -$107K ﹤0.01% 2458
2021
Q4 		$690 Buy
1,752
+18
+1% +$7.58K ﹤0.01% 2057
2021
Q3 		$776K Sell
1,734
-129
-7% -$46.2K ﹤0.01% 1996
2021
Q2 		$724K Buy
1,863
+56
+3% +$20K ﹤0.01% 2180
2021
Q1 		$649K Buy
1,807
+14
+0.8% +$6.19K ﹤0.01% 2131
2020
Q4 		$880K Buy
1,793
+149
+9% +$68.8K ﹤0.01% 1893
2020
Q3 		$533K Buy
1,644
+268
+19% +$91.3K ﹤0.01% 1970
2020
Q2 		$476K Buy
1,376
+45
+3% +$11.4K ﹤0.01% 1988
2020
Q1 		$283K Buy
1,331
+94
+8% +$29.8K ﹤0.01% 2126
2019
Q4 		$509K Sell
1,237
-8
-0.6% -$2.76K ﹤0.01% 2043
2019
Q3 		$419K Buy
1,245
+136
+12% +$50.7K ﹤0.01% 2127
2019
Q2 		$557K Buy
1,109
+17
+2% +$12K ﹤0.01% 1981
2019
Q1 		$1.08M Buy
1,092
+70
+7% +$65K ﹤0.01% 1645
2018
Q4 		$888K Sell
1,022
-67
-6% -$62.2K ﹤0.01% 1633
2018
Q3 		$1.13M Sell
1,089
-110
-9% -$108K ﹤0.01% 1726
2018
Q2 		$1.1M Buy
1,199
+219
+22% +$235K ﹤0.01% 1806
2018
Q1 		$955K Buy
980
+115
+13% +$105K ﹤0.01% 1867
2017
Q4 		$391K Buy
865
+53
+7% +$19.6K ﹤0.01% 2486
2017
Q3 		$337K Sell
812
-3
-0.4% -$1.13K ﹤0.01% 2558
2017
Q2 		$285K Buy
815
+55
+7% +$21.2K ﹤0.01% 2721
2017
Q1 		$391K Buy
760
+102
+16% +$42.2K ﹤0.01% 2359
2016
Q4 		$234K Buy
658
+1
+0.2% +$423 ﹤0.01% 2656
2016
Q3 		$352K Hold
657
– – ﹤0.01% 2324
2016
Q2 		$370K Buy
657
+194
+42% +$93.1K ﹤0.01% 2232
2016
Q1 		$218K Buy
463
+8
+2% +$3.6K ﹤0.01% 2537
2015
Q4 		$300 Buy
455
+6
+1% +$4.54K ﹤0.01% 2363
2015
Q3 		$353 Buy
449
+66
+17% +$80.5K ﹤0.01% 2227
2015
Q2 		$505 Buy
383
+273
+248% +$313K ﹤0.01% 2110
2015
Q1 		$114 Buy
+110
New +$72.7K ﹤0.01% 3111

Other funds holding ATRA

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CC
Centiva Capital New York $13.6B AUM 20% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s ATRA Position: Q2 2024 in Review

Manulife (Manufacturers Life Insurance) sold out of Atara Biotherapeutics (ATRA) in Q2 2024, closing a stake of 12,487 shares — an estimated $217K sold.

Manulife (Manufacturers Life Insurance) first reported a position in ATRA in Q1 2015 and held it in 37 quarters. The position peaked at $1.13M in Q3 2018. 48 funds tracked by Wall St. Rank hold ATRA as of Q2 2024.

  • Manulife (Manufacturers Life Insurance) reported no remaining Atara Biotherapeutics position as of Q2 2024 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 12,487 Atara Biotherapeutics shares in Q2 2024, an estimated $217K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Atara Biotherapeutics in Q1 2015 and held it in 37 quarters.
  • Manulife (Manufacturers Life Insurance)'s Atara Biotherapeutics position peaked at $1.13M in Q3 2018.
  • 48 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q2 2024.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2024, filed 14 Aug 2024.